RESMED INC (RMD) Stock Overview
NYSE:RMD - US7611521078 - Common Stock
RMD Key Statistics, Chart & Performance
The current stock price of RMD is 277.05 USD. In the past month the price decreased by -1.11%. In the past year, price increased by 13.14%.
RMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.13 | 231.38B | ||
| ISRG | INTUITIVE SURGICAL INC | 58 | 167.36B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.89 | 158.87B | ||
| SYK | STRYKER CORP | 30.53 | 149.98B | ||
| MDT | MEDTRONIC PLC | 16.8 | 119.16B | ||
| BDX | BECTON DICKINSON AND CO | 13.48 | 55.14B | ||
| IDXX | IDEXX LABORATORIES INC | 53.54 | 51.44B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.49 | 47.52B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.25 | 34.58B | ||
| DXCM | DEXCOM INC | 47.36 | 31.57B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.63 | 26.89B | ||
| PODD | INSULET CORP | 82.37 | 24.53B |
Related stock screener links
About RMD
Company Profile
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Company Info
RESMED INC
9001 Spectrum Center Blvd
San Diego CALIFORNIA 92123 US
CEO: MichaelJ.Farrell
Employees: 9980
Phone: 18587462400
RESMED INC / RMD FAQ
What is the stock price of RESMED INC today?
The current stock price of RMD is 277.05 USD. The price increased by 1.18% in the last trading session.
What is the ticker symbol for RESMED INC stock?
The exchange symbol of RESMED INC is RMD and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is RMD stock listed?
RMD stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for RESMED INC stock?
23 analysts have analysed RMD and the average price target is 295.22 USD. This implies a price increase of 6.56% is expected in the next year compared to the current price of 277.05. Check the RESMED INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is RESMED INC worth?
RESMED INC (RMD) has a market capitalization of 40.56B USD. This makes RMD a Large Cap stock.
How many employees does RESMED INC have?
RESMED INC (RMD) currently has 9980 employees.
What are the support and resistance levels for RESMED INC (RMD) stock?
RESMED INC (RMD) has a support level at 274.5 and a resistance level at 291.44. Check the full technical report for a detailed analysis of RMD support and resistance levels.
Is RESMED INC (RMD) expected to grow?
The Revenue of RESMED INC (RMD) is expected to grow by 9.22% in the next year. Check the estimates tab for more information on the RMD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy RESMED INC (RMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RMD, evaluating the profitability, health, valuation and growth aspects
- RESMED INC (RMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- RESMED INC (RMD) Sales and EPS estimates to see what analysts future expectations are.
- RESMED INC (RMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- RESMED INC (RMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- RESMED INC (RMD) Stock Chart to make your own analysis
- RESMED INC (RMD) Latest news and press-releases to stay up to date.
Does RESMED INC (RMD) stock pay dividends?
RESMED INC (RMD) has a dividend yield of 0.87%. The yearly dividend amount is currently 2.12. Check the full fundamental report for a detailed analysis of RMD dividend history, reliability and sustainability.
When does RESMED INC (RMD) report earnings?
RESMED INC (RMD) will report earnings on 2025-10-22.
What is the Price/Earnings (PE) ratio of RESMED INC (RMD)?
The PE ratio for RESMED INC (RMD) is 29.01. This is based on the reported non-GAAP earnings per share of 9.55 and the current share price of 277.05 USD. Check the full fundamental report for a full analysis of the valuation metrics for RMD.
What is the Short Interest ratio of RESMED INC (RMD) stock?
The outstanding short interest for RESMED INC (RMD) is 6.15% of its float. Check the ownership tab for more information on the RMD short interest.
RMD Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to RMD. When comparing the yearly performance of all stocks, RMD turns out to be only a medium performer in the overall market: it outperformed 64.84% of all stocks.
RMD Fundamental Analysis
ChartMill assigns a fundamental rating of 8 / 10 to RMD. Both the health and profitability get an excellent rating, making RMD a very profitable company, without any liquidiy or solvency issues.
RMD Financial Highlights
Over the last trailing twelve months RMD reported a non-GAAP Earnings per Share(EPS) of 9.55. The EPS increased by 23.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 27.22% | ||
| ROA | 17.14% | ||
| ROE | 23.47% | ||
| Debt/Equity | 0.11 |
RMD Forecast & Estimates
23 analysts have analysed RMD and the average price target is 295.22 USD. This implies a price increase of 6.56% is expected in the next year compared to the current price of 277.05.
For the next year, analysts expect an EPS growth of 14.94% and a revenue growth 9.22% for RMD